Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 21, 2020; 26(15): 1745-1757
Published online Apr 21, 2020. doi: 10.3748/wjg.v26.i15.1745
Published online Apr 21, 2020. doi: 10.3748/wjg.v26.i15.1745
Figure 4 MiR-432-5p regulates PPME1 expression in pancreatic carcinoma.
A: Three possible mRNAs regulated by miR-432-5p were selected and are presented in a Venn diagram; B and C: The expression levels of three target mRNAs were assessed after overexpression of miR-432-5p; D and E: The protein levels of three possible proteins were assessed after overexpression of miR-432-5p; F: The binding sites between PPME1 and miR-432-5p; G: Luciferase activity of miR-432-5p mimic with PPME1-WT or PPME1-MUT; H and I: PPME1 expression regulation by miR-432-5p mimic or inhibitor in Hs766T cells; J: PPME1 expression in pancreatic carcinoma tissues; K: MiR-432-5p inversely regulates PPME1 expression. aP < 0.05, bP < 0.01.
- Citation: Xu T, Lei T, Li SQ, Mai EH, Ding FH, Niu B. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p. World J Gastroenterol 2020; 26(15): 1745-1757
- URL: https://www.wjgnet.com/1007-9327/full/v26/i15/1745.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i15.1745